U.S. equities should still deliver positive returns in 2026, but with much higher dispersion: expensive mega‑cap tech/semis look late‑cycle, while neglected healthcare, utilities, select consumer names and small/mid caps offer better risk‑reward.
Key 2026 Macro & Market Themes
- Late‑cycle, stimulus‑supported growth: Most participants see U.S. GDP around 2–3% in 2026, helped by fiscal stimulus, AI capex and resilient consumption, but with clear late‑cycle signs (high deficits, rich valuations, crowded trades).
- Index concentration and “end of easy indexing”: The top 10 names are nearly 40% of the S&P 500 and over half of Nasdaq, with cap‑weighted S&P at ~23x vs 17x equal‑weight, pushing the opportunity set toward under‑owned, cheaper segments.
- AI as double‑edged sword: AI is a secular productivity driver, but current capex cycle and cloud/semis margins may be peaking, suggesting rotation from “shovel sellers” to broader beneficiaries and quality compounders using AI well.
- Re‑rating of laggards: Panelists repeatedly highlight better value in small/mid caps, non‑Mag‑7 S&P names, healthcare, utilities, select consumer cyclicals and international equities (Asia/India/parts of Europe).
- Rates, debt and liquidity: 10‑year UST could drift toward 4.5–5% with large supply and deficits; still, easier bank regulation and some Fed cuts keep liquidity supportive for risk assets, including EM debt and credit.
Core Investment Themes for the Year
- Stock‑picking over passive cap‑weighted beta: Rich index valuations and concentration argue for active, valuation‑sensitive equity selection, especially outside the Mag 7 and in smaller caps.p
- “Second‑derivative AI” winners: Focus on companies improving productivity with AI (software, services, diagnostics, logistics) rather than over‑owned, capex‑heavy hyperscalers and semis where returns may normalize.
- Healthcare & GLP‑1 / longevity: Structural demand, GLP‑1 adoption and a coming wave of generics/biosimilars 2026–2036 support non‑pharma healthcare, quality med‑tech and select pharma/biosimilar players.
- Income & securitized credit: With a steepening curve and still‑elevated yields, active fixed income, especially IG credit biased to BBB, securitized/agency MBS and EM debt, offers attractive carry without needing big spread compression.
- Gold and real assets: After a huge run, gold remains supported by central‑bank demand, currency diversification and geopolitical risk; broader metals and some energy/utility exposure benefit from infrastructure, defense and energy‑transition capex.
- Experiences, tourism and “IP + real estate”: Experiential consumption (events, travel, destination real estate) and owners of unique venues or content libraries benefit from consumers prioritizing experiences over goods.
List of Best Ideas (Equities)
Very short, idea‑level justifications; all bottom‑up names are from the panel.
- Madison Square Garden Entertainment (MSGE): Unique live‑events assets in NYC, strong pricing power, trades at discount to asset value, direct play on high‑end experiential spending.
- Adtalem Global Education (ATGE): Scarce healthcare education capacity vs structural nursing and medical shortages, improved regulation, strong cash generation and buybacks after a temporary earnings hiccup.
- Affiliated Managers Group (AMG): Capital‑light stakes in high‑quality asset managers (incl. alts), aggressive buybacks, trades at ~10x earnings and a discount to private‑market value.
- Middleby (MIDD): Leading commercial food‑service equipment supplier, anchored by global quick‑service chains; portfolio actions/spin‑offs plus activist pressure to unlock value at a discount multiple.
- Prestige Consumer Healthcare (PBH): Durable OTC healthcare brands, repairing temporary manufacturing issues, deleveraging and buybacks at ~13x earnings and a large discount to private value.
- Select small‑/mid‑cap value basket (US): Target quality, cash‑generative businesses in consumer, industrials and healthcare where index crowding and weak research coverage left valuations attractive vs large‑cap growth.
- European quality exporters & infrastructure beneficiaries: Global leaders in niche industrials, healthcare and capital goods geared to European defense/infrastructure push and AI/productivity capex, often at cheaper valuations than U.S. peers.
- Utilities with grid/infrastructure leverage: Regulated utilities and transmission players positioned for rising electricity demand from AI data centers and electrification, with improving pricing and capex visibility.
- Select autos/legacy OEMs (e.g., GM/BMW): Benefit from rollback of aggressive EV mandates, resilience of ICE/hybrids and more rational capex, after prior derating.
- Gold producers / gold ETF overlay: Operating leverage to structurally higher gold price driven by official‑sector buying and demand for a non‑crypto store of value.
Fixed‑Income & Alternatives Ideas
- Gold ETF (e.g., SPDR Gold Shares): Ongoing central‑bank diversification from euros into gold and persistent geopolitical uncertainty keep a firm floor under prices.
- Annaly Capital Management (NLY): High‑beta mREIT geared to agency MBS with double‑digit yield; benefits from steeper curve and supportive agency MBS backdrop, though volatile.
- AGNC Investment (AGNC): More traditional agency mREIT, ~13% yield, attractive with modest funding relief and a favorable environment for agency MBS spreads.
- Lord Abbett Income Fund (LAGVX): Shorter‑duration IG‑tilted credit with flexible high‑yield sleeve, exploiting mispriced bonds and securitized assets rather than pure index exposure.
- Franklin Dynamic Municipal Bond ETF (FLMI): Tax‑efficient income with solid muni fundamentals as U.S. states enter the year in strong fiscal shape.
- Franklin Income (FRIAX): Balanced, multi‑asset income fund designed for uncertain markets, able to lean into bouts of volatility.
- Eaton Vance Emerging Markets Debt Opportunities (EADOX): High real yield (~10% SEC yield) with diversified hard‑ and local‑currency EM exposure and a proven team.
- Putnam Core Bond (PYTRX): High‑quality U.S. core bond exposure with meaningful securitized allocation; good core building block as active fixed income outperforms passive in this environment.
If you want, a next step can be to turn this into a concise, portfolio‑style allocation by asset class and theme (e.g., % to small‑cap value, % to gold, % to EM debt) tailored to your current positioning and risk budget.